ASARFI.BO · BSE
ASARFI HOSPITAL LIMITED
₹169.55
+2.51% (+₹4.15)
Prev. close
₹165.4
Volume
56,000
As of
23 Sept 2026
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About ASARFI HOSPITAL LIMITED
Asarfi Hospital Limited operates a hospital under the Asarfi Hospital name in India. The company offers healthcare services that focus on prevention, diagnosis, treatment, and rehabilitation. Asarfi Hospital Limited was incorporated in 2005 and is based in Dhanbad, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Mr. Udai Pratap Singh
Headquarters
Dhanbad
Website
asarfi.inExchange
View on BSE ↗Key stats
Market cap
₹325.46 Cr
P/E ratio (TTM)
18.3
EPS (TTM)
₹9.04
Beta (1Y · daily vs NIFTY 50)
1.10
Beta (5Y · monthly vs NIFTY 50)
-0.20
Shares float
57.06 L
EPS · quarter ended Jun 2026
₹2.17
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹70.70 Cr | ₹84.40 Cr | ₹120.57 Cr | ₹173.50 Cr | |
| EBITDA | ₹15.63 Cr | ₹17.72 Cr | ₹31.07 Cr | ₹37.98 Cr |
| ₹8.02 Cr | ₹4.16 Cr | ₹10.58 Cr | ₹16.66 Cr | |
| Diluted EPS | ₹4.07 | ₹2.31 | ₹5.37 | ₹8.47 |
Total expenses (as filed), Employee benefit expense, Other expenses have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹93.43 Cr | ₹154.09 Cr | ₹163.89 Cr | ₹193.16 Cr | |
| ₹17.20 Cr | ₹31.91 Cr | ₹48.56 Cr | ₹57.56 Cr | |
| Stockholders' equity | ₹41.84 Cr | ₹70.41 Cr | ₹80.98 Cr | ₹97.64 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹-2.07 Cr | ₹26.07 Cr | ₹-4.34 Cr | ₹18.30 Cr | |
| Investing cash flow | ₹-13.65 Cr | ₹-63.19 Cr | ₹-7.38 Cr | ₹-18.29 Cr |
| ₹16.82 Cr | ₹36.41 Cr | ₹12.56 Cr | ₹4.76 Cr | |
| Capital expenditure | ₹-20.14 Cr | ₹-46.07 Cr | ₹-11.43 Cr | ₹-18.11 Cr |
| End cash position | ₹1.30 Cr | ₹59.12 L | ₹1.45 Cr | ₹6.22 Cr |
Debt issued, Debt repaid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,846.4 | 37.1 | 5.37 | 13.7% | 0.06 | +11.9% | +12.3% |
| Divi's Laboratories Limited | ₹2.48 L Cr | ₹9,624 | 84.9 | 14.81 | 15.3% | 0.00 | +12.3% | +59.0% |
| Torrent Pharmaceuticals Limited | ₹1.88 L Cr | ₹4,985 | 78.8 | 22.38 | 25.8% | 1.79 | +21.5% | +36.5% |
| Apollo Hospitals Enterprise Limited | ₹1.28 L Cr | ₹8,835.5 | 61.5 | 13.52 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.20 L Cr | ₹686.7 | 181.0 | 13.70 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,170.1 | 25.9 | 4.28 | 18.6% | 0.46 | +18.4% | +12.0% |
| Cipla Limited | ₹1.12 L Cr | ₹1,384.1 | 33.2 | 3.25 | 11.3% | 0.02 | +2.1% | -10.3% |
| Laurus Labs Limited | ₹1.09 L Cr | ₹2,034 | 99.7 | 20.52 | 16.8% | 0.48 | +22.0% | +123.5% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Dr. Reddy's Laboratories Limited | ₹1.01 L Cr | ₹1,211.2 | 30.5 | 2.68 | 11.4% | 0.21 | +3.2% | -7.4% |
| Manipal Health Enterprises Limited | ₹99,126.82 Cr | ₹760.95 | 150.7 | 11.76 | 7.8% | 1.53 | +18.0% | — |
| ASARFI HOSPITAL LIMITED | ₹340.22 Cr | ₹172.9 | 19.1 | 3.48 | 17.1% | 0.59 | +42.6% | +26.2% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Concall transcripts
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.
Asarfi Hospital Consolidated June 2026 Net Sales at Rs 47.53 crore, up 33.22% Y-o-Y
Moneycontrol.com · 1 month ago